Loading...
Thumbnail Image
Publication

A new in vitro assay measuring direct interaction of nonsense suppressors with the eukaryotic protein synthesis machinery [preprint]

Ng, Martin Y.
Zhang, Haibo
Weil, Amy
Singh, Vijay
Jamiolkowski, Ryan M.
Baradaran-Heravi, Alireza
Roberge, Michel
Jacobson, Allan
Welch, Ellen
Goldman, Yale
... show 1 more
Embargo Expiration Date
Link to Full Text
Abstract

Nonsense suppressors (NonSups) treat premature termination codon (PTC) disorders by inducing the selection of near cognate tRNAs at the PTC position, allowing readthrough of the PTC and production of full-length protein. Studies of NonSup-induced readthrough of eukaryotic PTCs have been carried out using animals, cells or crude cell extracts. In these studies, NonSups can promote readthrough directly, by binding to components of the protein synthesis machinery, or indirectly, by inhibiting nonsense-mediated mRNA decay or by other mechanisms. Here we utilize a highly-purified in vitro system (Zhang et al., 2016. eLife 5: e13429) to measure exclusively direct NonSup-induced readthrough. Of 17 previously identified NonSups, 13 display direct effects, apparently via at least two different mechanisms. We can monitor such direct effects by single molecule FRET (smFRET). Future smFRET experiments will permit elucidation of the mechanisms by which NonSups stimulate direct readthrough, aiding ongoing efforts to improve the clinical usefulness of NonSups.

Source

bioRxiv 330506; doi: https://doi.org/10.1101/330506. Link to preprint on bioRxiv service.

Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.1101/330506
PubMed ID
Other Identifiers
Notes
Funding and Acknowledgements
Corresponding Author
Related Resources

Now published in ACS Medicinal Chemistry Letters doi: 10.1021/acsmedchemlett.8b00472

Related Resources
Repository Citation
Rights
The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It is made available under a CC-BY 4.0 International license.